2022
DATE
09 - 14
Vazyme Releases 2022 Semi-Annual Report: On Track to Be a Biotech Leader
Revenue hit $242 million, up 96.2% y-o-y.Net profit reached $92 million, up 56.67% y-o-y.R&D investment stood at $23 million, up 85.72% y-o-y. Vazyme recently released the 2022 semi-annual report, revealing the robust growth in the first half of the year. Vazyme has been stepping up R&D efforts over
Read More
2022
DATE
06 - 01
Vazyme Releases 2021 Annual Report: Announces More Efforts in Technology innovation and Together with Partners for a Better Future
NANJING, China, June 1, 2022 /PRNewswire/ -- Vazyme, China's leading biotechnology company, has...
Read More
2022
DATE
03 - 17
Vazyme and IFC Launch Cooperation on International Expansion
Biotechnology company Vazyme and the International Finance Corporation (IFC), a member of the World Bank Group, have agreed to cooperate on overseas expansion opportunities in some countries of three rigions, APAC, EU and Larin America,. Vazyme is exploring the possibility of constructing medical-di
Read More
2022
DATE
03 - 08
#BreakTheBias — Girls Can Do Whatever They Want To Do
#BreakTheBias — Girls Can Do Whatever They Want To Do
Read More
2022
DATE
01 - 28
Ready to Enter the Middle East Market, Vazyme Showcases Its COVID-19 Testing Solutions at Medlab Middle East 2022
DUBAI, UAE, Jan. 28, 2022 /PRNewswire/ -- Leading China-based biotech company Vazyme (688105.SH) participated in the 2022 edition of Medlab Middle East in the Dubai World Trade Centre (DWTC) from January 24th to 27th
Read More
  • Total 2 pages  Go to Page
  • Go

Subscribe to our Newsletter

Our vision is to lead in biotechnology by driving innovation relentlessly, pursuing the highest standards in quality of products and services, and creating value for our customers.

OUR PRODUCTS

MORE LINKS

CONTACT US

Address: Building D2, Hongfeng science and
Technology Park, Kechuang Road, Nanjing
Economic and Technological Development
Zone, Jiangsu Province, China
Tel:+86 400-969-0586
E-mail: service.medical@vazyme.com
Copyright @ 2022 Nanjing Vazyme Biotech Co.,Ltd. All Rights Reserved